Login / Signup

A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.

Abdallah DerbalahHesham S Al-SallamiChihiro HasegawaAbhishek GulatiStephen B Duffull
Published in: British journal of clinical pharmacology (2020)
Quantitative systems pharmacology (QSP) is a relatively new discipline within modelling and simulation that has gained wide attention over the past few years. The application of QSP models spans drug-target identification and validation, through all drug development phases as well as clinical applications. Due to their detailed mechanistic nature, QSP models are capable of extrapolating knowledge to predict outcomes in scenarios that have not been tested experimentally, making them an important resource in experimental and clinical pharmacology. However, these models are complicated to work with due to their size and inherent complexity. This makes many applications of QSP models for simulation, parameter estimation and trial design computationally intractable. A number of techniques have been developed to simplify QSP models into smaller models that are more amenable to further analyses while retaining their accurate predictive capabilities. Different simplification techniques have different strengths and weaknesses and hence different utilities. Understanding the utilities of different methods is essential for selection of the best method for a particular situation. In this paper, we have created an overall framework for model simplification techniques that allows a natural categorisation of methods based on their utility. We provide a brief description of the concept underpinning the different methods and example applications. A summary of the utilities of methods is intended to provide a guide to modellers in their model endeavours to simplify these complicated models.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • emergency department
  • metabolic syndrome
  • climate change
  • study protocol
  • phase ii
  • electronic health record
  • adverse drug
  • bioinformatics analysis